3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with barium in 1 studies
Studies (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Trials (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Recent Studies (post-2010) (3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole) | Studies (barium) | Trials (barium) | Recent Studies (post-2010) (barium) |
---|---|---|---|---|---|
68 | 2 | 18 | 8,069 | 45 | 921 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Briggs, CA; McKenna, DG; Piattoni-Kaplan, M | 1 |
1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and barium
Article | Year |
---|---|
Human alpha 7 nicotinic acetylcholine receptor responses to novel ligands.
Topics: Anti-Anxiety Agents; Barium; Benzylidene Compounds; Binding, Competitive; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Chloride Channels; Dose-Response Relationship, Drug; Humans; Isoxazoles; Ligands; Membrane Potentials; Nicotinic Agonists; Oocytes; Patch-Clamp Techniques; Pyridines; Pyrrolidines; Receptors, Nicotinic; RNA, Messenger | 1995 |